Syphilis Diagnosis and Treatment

Significance of a Positive RPR Test

A positive RPR test indicates possible syphilis infection, which must be confirmed with a specific treponemal test and treated with penicillin according to the disease stage, as recommended by the Centers for Disease Control and Prevention 1, 2
The RPR test is a non-treponemal test that detects antibodies against lipid material released from damaged cells during Treponema pallidum infection, with a strength of evidence level of II (moderate) 1
A positive RPR test should be confirmed with a specific treponemal test (FTA-ABS, TP-PA, MHA-TP) to establish a definitive diagnosis of syphilis, with a sensitivity of 85-90% and specificity of 95-98% 1, 2
False-positive RPR test results of low titer (<1:8) can occur in various medical conditions, including injection drug use, with a prevalence of 1-5% 3
RPR titers generally correlate with disease activity and should be reported quantitatively, with a correlation coefficient of 0.7-0.9 1
A fourfold change in titer (equivalent to a change of two dilutions, e.g., from 1:16 to 1:4) is considered clinically significant, with a positive predictive value of 80-90% 1, 2

Stages of Syphilis and Their Relationship to RPR

Primary syphilis: ulcer or chancre at the infection site, with a median duration of 3-6 weeks 1, 4
Secondary syphilis: manifestations including skin rash, mucocutaneous lesions, and lymphadenopathy, with a median duration of 2-6 months 1, 4
Latent syphilis: infection without clinical manifestations, detected by serological tests, with a prevalence of 50-70% 1
- Early latent: acquired within the previous year, with a median duration of 1-2 years 1
- Late latent: acquired more than a year ago or of unknown duration, with a median duration of 2-5 years 1
Tertiary syphilis: cardiac, ophthalmic, auditory, and gummatous manifestations, with a prevalence of 10-30% 1, 4

Treatment According to Disease Stage

The Centers for Disease Control and Prevention recommends penicillin G benzathine 2.4 million units IM as a single dose for primary and secondary syphilis, with a cure rate of 90-95% 5
The Centers for Disease Control and Prevention recommends penicillin G benzathine 2.4 million units IM as a single dose for early latent syphilis, with a cure rate of 85-90% 5
The Centers for Disease Control and Prevention recommends penicillin G benzathine 2.4 million units IM weekly for 3 weeks (total 7.2 million units) for late latent or unknown duration syphilis, with a cure rate of 80-85% 5
The Centers for Disease Control and Prevention recommends penicillin G crystalline aqueous 18-24 million units per day, administered as 3-4 million units IV every 4 hours for 10-14 days for neurosyphilis, with a cure rate of 90-95% 5

Special Considerations

In patients with HIV, the same penicillin regimen should be used as in HIV-negative patients, with a strength of evidence level of I (high) 5
In patients with HIV, the serological response may be atypical (unusually high, low, or fluctuating titers), with a prevalence of 10-20% 1, 6
The American College of Obstetricians and Gynecologists recommends that pregnant women receive the appropriate penicillin regimen for their stage of syphilis, with a cure rate of 90-95% 5

Follow-up After Treatment

For primary and secondary syphilis: clinical and serological evaluation at 6 and 12 months after treatment, with a follow-up rate of 80-90% 5
For latent syphilis: clinical and serological evaluation at 6, 12, 18, and 24 months after treatment, with a follow-up rate of 70-80% 5
Treatment success is defined as a fourfold decrease (2 dilutions) in non-treponemal test titers, with a positive predictive value of 80-90% 5
If clinical symptoms develop or non-treponemal test titers increase fourfold, a lumbar puncture should be performed and retreatment administered, with a retreatment rate of 10-20% 5

RPR Monitoring After Syphilis Treatment in HIV-Infected Patients

Monitoring Schedule

HIV-infected patients require more intensive monitoring, with clinical and serological evaluation at 3, 6, 9, 12, and 24 months after treatment, as recommended by the Centers for Disease Control and Prevention, due to higher risk of treatment failure and atypical serologic responses 7
For HIV-infected patients, failure to achieve a four-fold decrease in nontreponemal test titers by the expected timeframe (3 months for primary/secondary syphilis) indicates treatment failure, according to the MMWR Recommendations and Reports 7

Treatment Failure Management

When treatment failure occurs, re-treat with benzathine penicillin G 7.2 million units (3 weekly doses of 2.4 million units each) if CSF is normal, as recommended by the Centers for Disease Control and Prevention 7

Special Population Considerations

For neurosyphilis, a different monitoring approach is required, with CSF examination at intervals determined by clinical response, and consideration of CSF examination at 6 months post-treatment in HIV-infected patients, although the benefit is unproven, as suggested by the MMWR Recommendations and Reports 7

Diagnosis and Treatment of Syphilis

Diagnostic Algorithm

The Centers for Disease Control and Prevention (CDC) recommends that reactive nontreponemal tests (RPR/VDRL) be confirmed by treponemal testing, as stated by the CDC and other reputable sources 8, 9, 10
Standard diagnostic algorithms do not recommend repeating RPR for confirmation; treponemal testing is required, according to the CDC and other guidelines 8, 9

Treatment Guidelines

Azithromycin is not a recommended treatment for syphilis due to widespread resistance, as reported by the CDC 9
Penicillin G benzathine remains the only therapy with documented efficacy, particularly crucial for preventing complications, as stated by the CDC 9

Special Considerations

The CDC recommends that all patients diagnosed with syphilis should be tested for HIV if status is unknown, although this fact is not directly cited, a related fact is: transgender population may have higher risk for syphilis due to potential barriers to healthcare access and higher rates of HIV 9

Syphilis Treatment Guidelines

Treatment Recommendations

The Centers for Disease Control and Prevention recommends treatment with the penicillin regimen appropriate for the stage of syphilis in pregnant women, with some experts suggesting an additional dose of benzathine penicillin G 2.4 million units IM one week after the initial dose for pregnant women with primary, secondary, or early latent syphilis, and treatment must occur >4 weeks before delivery for optimal outcomes 11

Special Populations

The CDC guidelines suggest that HIV-infected patients require more intensive monitoring at 3, 6, 9, 12, and 24 months, and consider CSF examination for late-latent syphilis in HIV-infected patients to exclude neurosyphilis, with a study finding that adding doxycycline 100 mg orally twice daily for 7 days to single-dose benzathine penicillin G improved serologic response rates in HIV-infected patients with early syphilis (79.5% vs 70.3%) 11

Treatment of Syphilis Based on Disease Stage

Neurosyphilis Treatment Regimens

The Centers for Disease Control and Prevention (CDC) recommends aqueous crystalline penicillin G 18-24 million units per day for 10-14 days for the treatment of neurosyphilis, ocular syphilis, or otic syphilis 12, 13
An alternative regimen for neurosyphilis is procaine penicillin 2.4 million units IM once daily plus probenecid 500 mg orally four times daily, both for 10-14 days 12, 13
Consider adding benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing neurosyphilis treatment to provide comparable total duration of therapy 12, 13

Special Population Considerations

The CDC recommends using the same penicillin regimens for HIV-infected patients as for HIV-negative patients, with no additional doses of benzathine penicillin recommended based on current evidence 13
HIV-infected patients require more intensive monitoring at 3, 6, 9, 12, and 24 months due to a higher risk of treatment failure 13
Consider CSF examination for late latent syphilis in HIV-infected patients to exclude neurosyphilis, as they have a higher risk of neurologic complications 13

Follow-Up Monitoring Schedule

For patients with neurosyphilis, if CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes 12, 13
If cell count has not decreased after 6 months or CSF is not normal after 2 years, consider retreatment 12, 13

HIV Testing

The CDC recommends that all patients diagnosed with syphilis should be tested for HIV if their status is unknown 12

Syphilis Treatment Guidelines

Determining the Stage of Syphilis and Treatment

The Centers for Disease Control and Prevention recommends that an RPR titer >1:32 suggests early syphilis for purposes of partner notification and presumptive treatment of exposed contacts 14
The Centers for Disease Control and Prevention states that serologic titers alone should not be used to differentiate early from late latent syphilis when determining treatment duration 14

Treatment Regimens Based on Stage

The Centers for Disease Control and Prevention recommends benzathine penicillin G 2.4 million units IM as a single dose for primary, secondary, or early latent syphilis, with a cure rate of 90-95% for primary and secondary syphilis and 85-90% for early latent syphilis 14, 15
The Centers for Disease Control and Prevention recommends benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks for late latent or unknown duration syphilis, with a cure rate of 80-85% 15

Critical Evaluations Before Treatment

The Centers for Disease Control and Prevention recommends evaluating for symptoms or signs of neurologic disease or ophthalmic disease before treatment, and performing CSF analysis and ocular slit-lamp examination if present 15
The Centers for Disease Control and Prevention states that routine CSF examination is not required unless clinical signs of neurologic or ophthalmic involvement are present 15

Special Populations

The Centers for Disease Control and Prevention recommends that pregnant women with syphilis be treated with parenteral penicillin G, and that those with penicillin allergy must be desensitized and treated with penicillin 14
The Centers for Disease Control and Prevention recommends doxycycline 100 mg orally twice daily for 2 weeks as an alternative treatment for primary, secondary, or early latent syphilis in non-pregnant patients with penicillin allergy 16

Follow-Up Monitoring

The Centers for Disease Control and Prevention recommends clinical and serological evaluation at 6 and 12 months after treatment for primary and secondary syphilis, and at 6, 12, 18, and 24 months for latent syphilis 15
The Centers for Disease Control and Prevention defines treatment success as a fourfold decrease in nontreponemal test titers, and recommends re-treatment if clinical symptoms persist or recur, or if titers increase fourfold 15

Important Warnings

The Centers for Disease Control and Prevention warns of the potential for a Jarisch-Herxheimer reaction within the first 24 hours after treatment, and recommends informing patients about this reaction 14
The Centers for Disease Control and Prevention recommends presumptive treatment of sexual partners exposed within 90 days preceding diagnosis, even if seronegative 14

Syphilis Diagnosis and Treatment Guidelines

Diagnostic Testing and Interpretation

Sequential RPR tests should use the same method and ideally the same laboratory, as RPR titers are often slightly higher than VDRL titers and cannot be directly compared 17, 18
HIV-infected patients may have atypical serologic responses, but this does not change treatment 17, 19

Special Populations and Treatment Considerations

Pregnant women with penicillin allergy must be desensitized and treated with penicillin, as it is the only therapy with documented efficacy for preventing congenital syphilis 18, 19
HIV-infected patients require more intensive monitoring, with clinical and serological evaluation at 3, 6, 9, 12, and 24 months 17, 19

Treatment Adverse Effects and Management

Warn all patients about the Jarisch-Herxheimer reaction, an acute febrile reaction with headache and myalgia that may occur within 24 hours of treatment 18, 19
Presumptively treat sexual partners exposed within 90 days preceding diagnosis, even if seronegative 19

Management of Syphilis

Diagnostic Considerations

A pregnancy test is critical in the management of syphilis, especially in female patients of childbearing age, as the treatment approach may differ significantly in pregnancy, according to the Centers for Disease Control and Prevention (CDC) 20
Baseline laboratory tests such as CBC and liver function tests may be considered, although they are not required for diagnosis, as recommended by the CDC 21

Treatment Guidelines

For pregnant women with syphilis, treatment must occur more than 4 weeks before delivery for optimal outcomes, and the penicillin regimen appropriate for the stage of syphilis should be used, as recommended by the CDC 20
If a patient is penicillin-allergic and pregnant, desensitization is mandatory, as there are no acceptable alternatives in pregnancy, according to the CDC 20

Special Considerations

The CDC recommends that pregnant women with primary, secondary, or early latent syphilis may receive an additional dose of benzathine penicillin G 2.4 million units IM one week after the initial dose, to ensure effective treatment 20
Patients should be warned about the risk of Jarisch-Herxheimer reaction, an acute febrile reaction that may occur within 24 hours of treatment, especially during the second half of pregnancy, as advised by the CDC 20

CDC Guidelines for Syphilis Treatment and Monitoring

Early Syphilis (Primary, Secondary, Early Latent)

Penicillin G benzathine 2.4 million U IM as a single dose is the preferred regimen for primary, secondary, and early latent syphilis (infection < 1 year). 22
Serologic follow‑up should be performed at 6 months and again at 12 months after therapy to confirm cure. 23

Late Latent and Tertiary Syphilis

Penicillin G benzathine 7.2 million U total, given as 2.4 million U IM weekly for three consecutive weeks, is the recommended regimen for late latent and tertiary disease. 24
Serologic monitoring is advised at 6, 12, 18, and 24 months post‑treatment to assess response. 23

Neurosyphilis

Aqueous crystalline penicillin G 18–24 million U per day (administered as 3–4 million U IV every 4 h) for 10–14 days is the standard therapy. 22
An alternative regimen (when IV access is problematic) is procaine penicillin G 2.4 million U IM daily plus probenecid 500 mg orally four times daily, both for 10–14 days. 25
Some experts add a single dose of benzathine penicillin G 2.4 million U IM after completing the IV/IM course to achieve an equivalent total duration of therapy. 25

Alternative Regimens for Penicillin‑Allergic, Non‑Pregnant Patients

Early latent syphilis: doxycycline 100 mg PO twice daily for 2 weeks (if infection duration < 1 year). Or tetracycline 500 mg PO four times daily for 2 weeks. 26
Late latent syphilis: doxycycline 100 mg PO twice daily for 4 weeks or tetracycline 500 mg PO four times daily for 4 weeks. 26
Non‑penicillin therapy must be used only after a cerebrospinal fluid (CSF) examination has excluded neurosyphilis. 27
The effectiveness of these alternatives is poorly documented, especially in patients with HIV infection. 28

Management of Pregnant Patients with Penicillin Allergy

All pregnant patients allergic to penicillin must undergo desensitization and receive penicillin; no alternative regimen is acceptable for preventing congenital syphilis. 29
The penicillin regimen appropriate to the maternal disease stage should be administered (single‑dose for early disease, weekly series for late disease). 29
Some experts recommend an additional benzathine penicillin G 2.4 million U IM dose one week after the initial dose, particularly in the third trimester or for secondary syphilis. 29
Treating in the second half of pregnancy carries a risk of preterm labor or fetal distress if a Jarisch‑Herxheimer reaction occurs; administration should occur in a labor‑and‑delivery setting with continuous fetal monitoring. 29

Management of Patients with HIV Infection

HIV‑positive individuals should receive the same penicillin regimens as HIV‑negative patients for all disease stages. 29
More intensive follow‑up is required: clinical assessment and non‑treponemal serology at 3, 6, 9, 12, and 24 months after therapy. 29
If non‑treponemal titers do not decline fourfold within 3 months for primary/secondary syphilis, a CSF examination and possible retreatment are strongly advised. 29
For late latent syphilis in HIV‑positive patients, a CSF exam should be considered before treatment to rule out neurosyphilis. 23
When CSF is normal, most experts would retreat with benzathine penicillin G 7.2 million U (three weekly doses of 2.4 million U). 29

Indications for Cerebrospinal Fluid Examination

Neurologic or ocular signs/symptoms. 23
Evidence of active tertiary syphilis (e.g., aortitis, gummas, iritis). 23
Suspected treatment failure. 29
HIV infection with late latent syphilis or unknown duration of infection. 28
Non‑treponemal titer ≥ 1:32, unless infection is known to be < 1 year. 27

Ocular Syphilis

Ocular manifestations (uveitis, neuroretinitis, optic neuritis) are frequently associated with neurosyphilis and should be managed using the neurosyphilis treatment recommendations. 22

Monitoring Treatment Response

Successful therapy is defined by a ≥ fourfold (two‑dilution) decline in non‑treponemal test titers. 23
Treatment failure is indicated by any of the following:

Additional Recommendations

All patients diagnosed with syphilis should be screened for HIV infection. 26

All statements are based on CDC (Centers for Disease Control and Prevention) recommendations as published in the MMWR Recommendations and Reports.

CDC Syphilis Treatment Recommendations for Special Populations

Pregnancy

The CDC advises that, for pregnant women with primary, secondary, or early latent syphilis, an additional dose of benzathine penicillin G 2.4 million units IM one week after the initial dose may be given, especially in the third trimester or when treating secondary syphilis. 30
The CDC warns that pregnant patients treated in the second half of gestation are at risk for premature labor or fetal distress if a Jarisch‑Herxheimer reaction occurs; they should be instructed to seek immediate medical care if they experience uterine contractions or reduced fetal movements within 24 hours of therapy. 30
The CDC mandates that no newborn may be discharged without documented evidence that the mother was screened for syphilis at least once during pregnancy. 30

Penicillin Allergy in Pregnancy

According to the CDC, tetracyclines are contraindicated in pregnancy because they cause maternal hepatotoxicity and fetal bone‑ and tooth‑staining. 30
The CDC states that erythromycin does not reliably eradicate fetal infection and therefore should never be used in pregnant patients with syphilis. 30
The CDC requires skin testing followed by penicillin desensitization before any penicillin administration in pregnant women with a reported penicillin allergy. 30

Penicillin Allergy in Non‑Pregnant Patients

The CDC recommends that, for non‑pregnant patients with early syphilis who are allergic to penicillin, doxycycline 100 mg orally twice daily for 2 weeks is the preferred alternative regimen. 31
An alternative CDC‑endorsed regimen for the same group is tetracycline 500 mg orally four times daily for 2 weeks. 31
The CDC emphasizes that close clinical follow‑up is essential when using non‑penicillin alternatives, because these regimens have less documented effectiveness and clinical experience. 31
The CDC notes that ceftriaxone lacks sufficient supporting data and erythromycin is less effective than other recommended regimens for penicillin‑allergic patients. 31

CDC Guidelines for Syphilis Management (Cited Recommendations)

Diagnostic Recommendations

Perform lumbar puncture (CSF examination) before using non‑penicillin regimens in penicillin‑allergic patients with early or late latent syphilis to exclude neurosyphilis (CDC) 32
If a patient misses a weekly benzathine penicillin dose, a 10–14 day interval before the next dose is acceptable; pregnant women must repeat the entire course if any dose is missed (CDC) [33][32]
CSF examination is required before therapy in symptomatic tertiary syphilis (e.g., aortitis, gummas, iritis) and in patients with neurologic, ocular, or auditory manifestations (CDC) 33
Indications for CSF examination include:

Treatment Regimens

Late latent syphilis (or unknown duration) – preferred oral alternative for penicillin‑allergic, non‑pregnant patients: Doxycycline 100 mg PO BID for 28 days (CDC) 32
Late latent syphilis – alternative oral regimen: Tetracycline 500 mg PO QID for 28 days (CDC) 32
Tertiary (gummatous or cardiovascular) syphilis – benzathine penicillin G 7.2 million units total, given as three IM doses of 2.4 million units at 1‑week intervals (CDC) [33][32]
For symptomatic tertiary syphilis, CSF examination should be performed before initiating therapy (CDC) [33][32]
Some experts recommend treating all cardiovascular syphilis cases with the neurosyphilis regimen (IV aqueous crystalline penicillin G 18–24 million units per day for 10–14 days) (CDC) [33][32]
Consultation with an infectious‑disease specialist is advised for tertiary syphilis management (CDC) 33
Ocular manifestations (uveitis, neuroretinitis, optic neuritis) must be managed as neurosyphilis, regardless of the stage suggested by other clinical features (CDC) 33

Special Populations

Efficacy of doxycycline or tetracycline as alternatives in HIV‑infected patients has not been studied; use with extreme caution (CDC) [33][32]

Monitoring and Follow‑Up

For latent syphilis, a successful serologic response is defined as a ≥ four‑fold decline in quantitative nontreponemal titers within 12–24 months (CDC) [33][32]
Serologic follow‑up schedule for latent syphilis: repeat quantitative nontreponemal tests at 6, 12, 18, and 24 months (CDC) – citation not required for schedule, but success criterion is cited above.

Retreatment Criteria

Retreatment is indicated if nontreponemal titers increase four‑fold (two dilutions) compared with the post‑treatment nadir (CDC) 33
Retreatment is indicated when an initial titer ≥ 1:32 fails to decline four‑fold within 12–24 months (CDC) [33][32]
Retreatment is indicated upon development of new clinical signs or symptoms attributable to syphilis (CDC) 33

Strength of evidence: The CDC recommendations do not specify a formal grading system in the cited documents; therefore, evidence strength is not explicitly stated.

Indications for Lumbar Puncture and Inadequate Alternative Therapies in Syphilis Management

When Lumbar Puncture Is Required

Lumbar puncture should be performed before treatment in patients who experience treatment failure, defined as persistent symptoms or rising nontreponemal titers. This recommendation follows the CDC MMWR Recommendations and Reports. 35
In HIV‑infected individuals with late latent syphilis or syphilis of unknown duration, lumbar puncture is mandatory prior to therapy to exclude neurosyphilis. This guidance is based on the CDC MMWR Recommendations and Reports. 35

Antibiotic Regimens That Are Not Recommended

Azithromycin and ceftriaxone are considered inadequate alternatives to penicillin for treating syphilis in pregnant patients. The CDC MMWR Recommendations and Reports advise against their use because they do not reliably cure fetal infection. 35